Join leading diabetes experts to explore the latest in diabetes technology and its practical application in primary care. This session covers crucial updates for GPs, including the shift towards using Continuous Glucose Monitors (CGM) as a powerful behaviour change tool for patients with type 2 diabetes, with evidence showing significant A1C reductions. Learn about new, simplified screening algorithms for diabetes-related liver fibrosis using the FIB-4 index, a critical step to prevent severe outcomes. Plus, discover the transformative impact of AI scribes, now used by 60% of GPs to save time, reduce costs, and enhance patient focus.